Documentos relacionados

1. CRISPR-Cas9-mediated gene therapy in lung cancer.
2. Revolutionizing Lung Cancer Treatment: Innovative CRISPR-Cas9 Delivery Strategies.
3. CRISPR-Directed Gene Editing as a Method to Reduce Chemoresistance in Lung Cancer Cells.
4. ZEB1 and ZEB2 gene editing mediated by CRISPR/Cas9 in A549 cell line.
5. Exon skipping induced by CRISPR-directed gene editing regulates the response to chemotherapy in non-small cell lung carcinoma cells.
6. Applications of CRISPR technology to lung cancer research.
7. Design of a self-driven probiotic-CRISPR/Cas9 nanosystem for sono-immunometabolic cancer therapy.
8. Nonviral CRISPR/Cas9 mutagenesis for streamlined generation of mouse lung cancer models.
9. A multifunctional non-viral vector for the delivery of MTH1-targeted CRISPR/Cas9 system for non-small cell lung cancer therapy.
10. Monitoring autochthonous lung tumors induced by somatic CRISPR gene editing in mice using a secreted luciferase.